Yueju pill rapidly induces antidepressant-like effects and acutely enhances BDNF expression in mouse brain

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Xue, Wenda ^a   Zhou, Xin ^a   Yi, Nan ^b   Jiang, Lihua ^c   Tao, Weiwei ^a   Wu, Runjie ^a   Wang, Dan ^a   Jiang, Jingjing ^a   Ge, Xiaoyin ^a   Wang, Yuyue ^a   Wu, Haoxin ^a   Chen, Gang ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b NANJING NORMAL UNIVERSITY   (China)

^c MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CHINESE DRUG; ELONGATION FACTOR 2; HERBACEOUS AGENT; KETAMINE; MESSENGER RNA; UNCLASSIFIED DRUG; YUEJU;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DEPRESSION; DRUG MECHANISM; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 84877953202     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/184367     Document Type: Article

References (34)

1. Kessler R. C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K. R., Rush A. J., Walters E. E., Wang P. S., The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Journal of the American Medical Association 2003 289 23 3095 3105 2-s2.0-0037831023 10.1001/jama.289.23.3095 (Pubitemid 37432885)
2. Trivedi M. H., Rush A. J., Wisniewski S. R., Nierenberg A. A., Warden D., Ritz L., Norquist G., Howland R. H., Lebowitz B., McGrath P. J., Shores-Wilson K., Biggs M. M., Balasubramani G. K., Fava M., Evaluation of outcomes with citalopram for depression using measurement-based care in STAR- D: implications for clinical practice. American Journal of Psychiatry 2006 163 1 28 40 2-s2.0-30044433660 10.1176/appi.ajp.163.1.28
3. Brunoni A. R., Teng C. T., Correa C., Imamura M., Brasil-Neto J. P., Boechat R., Rosa M., Caramelli P., Cohen R., del Porto J. A., Boggio P. S., Fregni F., Neuromodulation approaches for the treatment of major depression: challenges and recommendations from a working group meeting. Arquivos de Neuro-Psiquiatria 2010 68 3 433 451 2-s2.0-77954594804
4. Fava M., Diagnosis and definition of treatment-resistant depression. Biological Psychiatry 2003 53 8 649 659 2-s2.0-0038147546 10.1016/S0006-3223(03) 00231-2 (Pubitemid 39658481)
5. Zarate C. A. Jr., Singh J. B., Carlson P. J., Brutsche N. E., Ameli R., Luckenbaugh D. A., Charney D. S., Manji H. K., A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry 2006 63 8 856 864 2-s2.0-33746896935 10.1001/archpsyc.63.8.856 (Pubitemid 44188478)
6. Berman R. M., Cappiello A., Anand A., Oren D. A., Heninger G. R., Charney D. S., Krystal J. H., Antidepressant effects of ketamine in depressed patients. Biological Psychiatry 2000 47 4 351 354 2-s2.0-0033969685 10.1016/S0006- 3223(99)00230-9 (Pubitemid 30109248)
7. Price R. B., Nock M. K., Charney D. S., Mathew S. J., Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biological Psychiatry 2009 66 5 522 526 2-s2.0-68049121850 10.1016/j.biopsych.2009.04.029
8. Li N., Lee B., Liu R. J., Banasr M., Dwyer J. M., Iwata M., Li X. Y., Aghajanian G., Duman R. S., mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010 329 5994 959 964 2-s2.0-77955909841 10.1126/science.1190287
9. Autry A. E., Adachi M., Nosyreva E., Na E. S., Los M. F., Cheng P. F., Kavalali E. T., Monteggia L. M., NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011 475 7354 91 96 2-s2.0-79960057257 10.1038/nature10130
10. Zhang Z. J., Kang W. H., Li Q., Tan Q. R., The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies. Journal of Psychiatric Research 2007 41 10 828 836 2-s2.0-34247891715 10.1016/j.jpsychires.2006.08.002 (Pubitemid 46693897)
11. An L., Zhang Y. Z., Yu N. J., Liu X. M., Zhao N., Yuan L., Chen H. X., Li Y. F., The total flavonoids extracted from Xiaobuxin-Tang up-regulate the decreased hippocampal neurogenesis and neurotrophic molecules expression in chronically stressed rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008 32 6 1484 1490 2-s2.0-47749100014 10.1016/j.pnpbp.2008.05.005
12. Hu Y., Liu P., Guo D. H., Rahman K., Wang D. X., Xie T. T., Antidepressant effects of the extract YZ-50 from Polygala tenuifolia in chronic mild stress treated rats and its possible mechanisms. Pharmaceutical Biology 2010 48 7 794 800 2-s2.0-77954122271 10.3109/13880200903280034
13. Wei X. H., Cheng X. M., Shen J. S., Wang Z. T., Antidepressant effect of Yueju-Wan ethanol extract and its fractions in mice models of despair. Journal of Ethnopharmacology 2008 117 2 339 344 2-s2.0-41949128276 10.1016/j.jep.2008. 02.004
14. Wei X. H., Xu X. D., Shen J. S., Wang Z. T., Antidepressant effect of Yueju ethanol extract and its constituents in mice models of despair. China Pharmacy 2009 20 3 166 168
15. Maeng S., Zarate C. A. Jr., Du J., Schloesser R. J., McCammon J., Chen G., Manji H. K., Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biological Psychiatry 2008 63 4 349 352 2-s2.0-38349186799 10.1016/j.biopsych.2007.05.028 (Pubitemid 351146651)
16. Mingmalairak S., Tohda M., Murakami Y., Matsumoto K., Possible involvement of signal transducers and activators of transcription 3 system on depression in the model mice brain. Biological and Pharmaceutical Bulletin 2010 33 4 636 640 2-s2.0-77950909228 10.1248/bpb.33.636
17. Steru J., Chermat R., Thierry B., Mico J. A., Lenegre A., Steru M., Simon P., Porsolt R. D., The automated tail suspension test: a computerized device which differentiates psychotropic drugs. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1987 11 6 659 671 2-s2.0-0023521172 (Pubitemid 18004312)
18. Overmier J. B., Seligman M. E., Effects of inescapable shock upon subsequent escape and avoidance responding. Journal of Comparative and Physiological Psychology 1967 63 1 28 33
19. Cryan J. F., Markou A., Lucki I., Assessing antidepressant activity in rodents: recent developments and future needs. Trends in Pharmacological Sciences 2002 23 5 238 245 2-s2.0-0036570222 10.1016/S0165-6147(02)02017-5 (Pubitemid 34465544)
20. Cryan J. F., Mombereau C., Vassout A., The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neuroscience and Biobehavioral Reviews 2005 29 4-5 571 625 2-s2.0-19944380200 10.1016/j.neubiorev.2005.03.009 (Pubitemid 40755457)
21. Bechtholt-Gompf A. J., Smith K. L., John C. S., Kang H. H., Carlezon W. A. Jr., Cohen B. M., Ongur D., CD-1 and Balb/cJ mice do not show enduring antidepressant-like effects of ketamine in tests of acute antidepressant efficacy. Psychopharmacology 2011 215 4 689 695
22. +/- heterozygous null mice. Neuropharmacology 2012 62 1 391 397
23. Réus G. Z., Stringari R. B., Ribeiro K. F., Ferraro A. K., Vitto M. F., Cesconetto P., Souza C. T., Quevedo J., Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behavioural Brain Research 2011 221 1 166 171 2-s2.0-79953070155 10.1016/j.bbr.2011.02.024
24. Koike H., Iijima M., Chaki S., Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression. Behavioural Brain Research 2011 224 1 107 111 2-s2.0-79959350106 10.1016/j.bbr.2011.05.035
25. Martinowich K., Manji H., Lu B., New insights into BDNF function in depression and anxiety. Nature Neuroscience 2007 10 9 1089 1093 2-s2.0-34548336779 10.1038/nn1971 (Pubitemid 47339961)
26. Racagni G., Popoli M., Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues in Clinical Neuroscience 2008 10 4 385 400 2-s2.0-59149089706
27. Tsankova N. M., Berton O., Renthal W., Kumar A., Neve R. L., Nestler E. J., Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nature Neuroscience 2006 9 4 519 525 2-s2.0-33645357786 10.1038/nn1659
28. Conti A. C., Cryan J. F., Dalvi A., Lucki I., Blendy J. A., cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. Journal of Neuroscience 2002 22 8 3262 3268 2-s2.0-0037092432 (Pubitemid 35379213)
29. Hiking H., Aota K., Kuwano D., Takemoto T., Structure and absolute configuration of α -rotunol and β -rotunol, sesquiterpenoids of Cyperus rotundus. Tetrahedron 1971 27 19 4831 4836 2-s2.0-0001069057
30. Thebtaranonth C., Thebtaranonth Y., Wanauppathamkul S., Yuthavong Y., Antimalarial sesquiterpenes from tubers of Cyperus rotundus: structure of 10,12-peroxycalamenene, a sesquiterpene endoperoxide. Phytochemistry 1995 40 1 125 128 2-s2.0-0029360451 10.1016/0031-9422(95)00260-E
31. Sonwa M. M., König W. A., Chemical study of the essential oil of Cyperus rotundus. Phytochemistry 2001 58 5 799 810 2-s2.0-0035900358 10.1016/S0031-9422(01)00301-6 (Pubitemid 33055394)
32. Nakai Y., Kido T., Hashimoto K., Kase Y., Sakakibara I., Higuchi M., Sasaki H., Effect of the rhizomes of Atractylodes lancea and its constituents on the delay of gastric emptying. Journal of Ethnopharmacology 2003 84 1 51 55 2-s2.0-0037217503 10.1016/S0378-8741(02)00260-X (Pubitemid 36034236)
33. Suto K., Kakinuma S., Ito Y., Sagara K., Iwasaki H., Itokawa H., Determination of atractylon in Atractylodes rhizome using supercritical fluid chromatography on-line coupled with supercritical fluid extraction by the direct induction method. Journal of Chromatography A 1998 810 1-2 252 255 2-s2.0-0031836403 10.1016/S0021-9673(98)00225-8 (Pubitemid 28288250)
34. Tsuneki H., Ma E. L., Kobayashi S., Sekizaki N., Maekawa K., Sasaoka T., Wang M. W., Kimura I., Antiangiogenic activity of β -eudesmol in vitro and in vivo. European Journal of Pharmacology 2005 512 2-3 105 115 2-s2.0-17444410829 10.1016/j.ejphar.2005.02.035 (Pubitemid 40544343)